BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT06979453: enrollment: not set → 366 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT04924075: enrollment: not set → 322 participants.
IONIS PHARMACEUTICALS INC (IONS)
Clinical trial NCT07298447: enrollment: not set → 20 participants.
ASTRAZENECA PLC (AZN)
Clinical trial NCT05952557: enrollment: not set → 5500 participants.
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Clinical trial NCT05422222 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 210 participants
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT06635486 updates: 1. completion date: 2026-06-01 → 2027-06-01 2. primary completion date: 2026-06-01 → 2027-06-01 3. enrollment: not set → 90 participants
INNOVATION PHARMACEUTICALS INC. (IPIX)
Clinical trial NCT07035769: enrollment: not set → 88 participants.
NOVARTIS AG (NVSEF)
Clinical trial NCT07454889 updates: 1. start date: 2026-03-31 → 2026-05-31 2. enrollment: not set → 34 participants
MEDTRONIC PLC (MDT)
Clinical trial NCT06777368 updates: 1. completion date: 2033-07-01 → 2027-11-01 2. primary completion date: 2029-03-01 → 2027-11-01 3. enrollment: not set → 225 participants
ABBVIE INC. (ABBV)
Clinical trial NCT06772623: enrollment: not set → 252 participants.